China Inherited Ventricular Arrhythmias Registry

Status Recruiting

Clinical Trial Summary

This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.

Clinical Trial Description

In China, the prevalence and risk factors of malignant ventricular arrhythmias remain unclear. In addition, mainstream treatment relies on implantable devices and medication. China Malignant Ventricular Arrhythmias Study is a nation-wide complex consisting of several interrelated studies, with the aim of building a risk stratification as well as an efficient and economic strategy for early prevention and treatment.

Inherited Ventricular Arrhythmias Registry, as a part of China Malignant Ventricular Arrhythmias Study, is an observational, prospective, multi-center registry, aiming at exploring the correlation between genotype and phenotype for inherited structural ventricular arrhythmias, thus helping molecular diagnosis and risk stratification of these conditions. 500 patients with definitive diagnosis will be recruited consecutively from 10 major arrhythmia centers distributed in 6 areas in China. At study entry, participants will be interviewed and asked to sign the informed consent. Demographic characteristics, medical history, clinical features, laboratory tests, imaging pictures, medications, procedures, and in-hospital outcomes of patients will be abstracted from medical records by well-trained staffs. At the same time, blood samples will be collected to detect biological markers, like genes, inflammatory factors ,etc. Once enrolled, the participants will receive follow up every 6 mouths about condition of arrhythmia, medication, clinical events, etc. ;

Study Design

Related Conditions & MeSH terms

Ventricular Arrythmia

Clinical Trial Details

NCT number	NCT03880708
Study type	Observational
Source	China National Center for Cardiovascular Diseases
Contact	Yan YAO, MD,PhD
Phone	+86-13901121319
Email	ianyao@263.net.cn
Status	Recruiting
Phase
Start date	October 24, 2017
Completion date	October 24, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05791032` - Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study	N/A
Not yet recruiting	`NCT06063811` - Ventricular Tachycardia Ablation in LVAD Patients
Withdrawn	`NCT05049720` - ExtraVascular Implantable Cardiac Defibrillator Continued Access Study	N/A
Completed	`NCT04060680` - Extravascular ICD Pivotal Study	N/A
Not yet recruiting	`NCT04990089` - VIVO European Observational Registry
Recruiting	`NCT05418036` - Safety Assessment for Sotalol Protocol in Outpatient Unit	Phase 4
Recruiting	`NCT04264455` - Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis
Recruiting	`NCT03821051` - China Structural Ventricular Arrhythmias Registry
Recruiting	`NCT03041519` - Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias	N/A
Completed	`NCT03204981` - Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias	N/A
Recruiting	`NCT04239144` - Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease	N/A
Recruiting	`NCT05829993` - Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
Recruiting	`NCT05707637` - Bipolar Radio-frequency Ablation After Standard Unipolar Approach - Prospective Registry.
Completed	`NCT05357716` - Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
Recruiting	`NCT06158698` - CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine	Phase 3
Active, not recruiting	`NCT03495297` - A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing	N/A
Suspended	`NCT03502499` - Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation	N/A
Completed	`NCT04809701` - Non-vascular ICD Electrode Configuration Feasibility Study	N/A
Withdrawn	`NCT03258112` - Safety and Efficacy of Catheter Ablation of Idiopathic Ventricular Arrhythmias Arising From Cardiac Outflow Tracts	N/A
Completed	`NCT02099721` - Improve Sudden Cardiac Arrest Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.